Contents
Academic literature on the topic 'Récepteur des lipoprotéines de basse densité'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Récepteur des lipoprotéines de basse densité.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Récepteur des lipoprotéines de basse densité"
Frey-Fressart, V., D. Bonnefont-Rousselot, M. Gardès-Albert, C. Ferradini, J. Delattre, M. Auclair, C. Mazière, and JC Mazière. "Modifications des lipoprotéines de basse densité (LDL) par radiolyse γ de l'eau : reconnaissance par les récepteurs APO B/E et «scavenger», et cytotoxicité vis-à-vis de fibroblastes humains en culture." Journal de Chimie Physique 91 (1994): 1085–91. http://dx.doi.org/10.1051/jcp/1994911085.
Full textChapman, John Martin, Maryse Guérin, and Éric Bruckert. "Place des anomalies des lipoprotéines de basse densité (LDL) dans l’athérogénicité." Bulletin de l'Académie Nationale de Médecine 185, no. 1 (January 2001): 35–39. http://dx.doi.org/10.1016/s0001-4079(19)34587-x.
Full textBonnefont-Rousselot, D., J. Delattre, A. Galli, M. Gardès-Albert, and C. Ferradini. "Péroxydation des lipoprotéines de basse densité (LDL) par divers radicaux libres oxygénés produits par radiolyse gamma." Journal de Chimie Physique 88 (1991): 913–25. http://dx.doi.org/10.1051/jcp/1991880913.
Full textMakama, R. S., B. David, C. D. Aaron, H. W. Kehinde, J. Yayi, and I. J. Bala. "Haematological indices, liver function and lipid profile of broiler chickens fed graded levels of scent leaf (Ocimum gratissimmum L.) meal." Nigerian Journal of Animal Production 49, no. 3 (June 9, 2022): 73–81. http://dx.doi.org/10.51791/njap.v49i3.3534.
Full textMakama, R. S., B. David, C. D. Aaron, H. W. Kehinde, J. Yayi, and I. J. Bala. "Haematological indices, liver function and lipid profile of broiler chickens fed graded levels of scent leaf (Ocimum gratissimmum L.) meal." Nigerian Journal of Animal Production 49, no. 2 (March 8, 2022): 201–8. http://dx.doi.org/10.51791/njap.v49i2.3480.
Full textLECLERCQ, B. "Possibilités d’obtention et intérêt des génotypes maigres en aviculture." INRAE Productions Animales 2, no. 4 (October 10, 1989): 275–86. http://dx.doi.org/10.20870/productions-animales.1989.2.4.4421.
Full textAdemu, L. A., G. James, J. R. Rimamfenten, and E. E. Oko. "Trimethyl glycine (TMG) influences on blood biochemistry and organ indices of heat stressed growing rabbits." Nigerian Journal of Animal Production 49, no. 5 (May 26, 2023): 127–37. http://dx.doi.org/10.51791/njap.v49i5.3771.
Full textOloruntola, Olugbenga David, Simeon Olugbenga Ayodele, and Deborah Adebukola Oloruntola. "Effect of pawpaw (Carica papaya) leaf meal and dietary enzymes on broiler performance, digestibility, carcass and blood composition." Revue d’élevage et de médecine vétérinaire des pays tropicaux 71, no. 3 (October 23, 2018): 121. http://dx.doi.org/10.19182/remvt.31640.
Full textAntébi, Héléna, Laurence Zimmermann, Corinne Bourcier, Alexia Le Brun, Agnès Giudicelli, Guy Dutot, Virginie Colomb, et al. "Peroxydation in vitro et effet de l'administration en nutrition parentérale totale d'une émulsion lipidique à base d'huile d'olive sur la peroxydabilité des lipoprotéines de basse densité chez l'enfant." Nutrition Clinique et Métabolisme 10, no. 4 (January 1996): 41S—43S. http://dx.doi.org/10.1016/s0985-0562(96)80072-0.
Full textDuvillard, L., E. Florentin, F. Pont, J. M. Petit, S. Baillot Rudoni, A. Penfornis, and B. Verges. "O13 L’hyperinsulinisme endogéne isolé n’induit pas d’augmentation de la production des lipoprotéines de très basse densité (VLDL) : preuve à partir d’une étude cinétique réalisée chez des patients porteurs d’un insulinome." Diabetes & Metabolism 36 (March 2010): A4. http://dx.doi.org/10.1016/s1262-3636(10)70017-3.
Full textDissertations / Theses on the topic "Récepteur des lipoprotéines de basse densité"
Robbesyn, Fanny. "Effet protecteur des lipoprotéines de haute densité contre la signalisation des lipoprotéines de basse densité oxydées : étude du facteur de transcription Nuclear Factor-kappaB et du récepteur à l'epidermal growth factor." Toulouse 3, 2003. http://www.theses.fr/2003TOU30083.
Full textGueddari, Nai͏̈ma. "Mise en évidence et expression du récepteur aux LDL dans des lignées tumorales humaines : étude de sa régulation dans la lignée d'adénocarcinome pulmonaire A549." Toulouse 3, 1993. http://www.theses.fr/1993TOU30160.
Full textJedidi, Iness. "Oxydation des LDL in vitro : mécanismes moléculaires de protection par l'aminoguanidine, régulation de l'expression de récepteur "scavenger" CD36 dans les macrophages humains par les lipides oxydés." Paris 5, 2004. http://www.theses.fr/2004PA05P616.
Full textThe uptake of oxidized low density lipoproteins (oxLDL) by macrophages is a key event involved in the initiation and development of atherosclerosis. The first study aimed at evaluating the protective effect of aminoguanidine (AMG) towards both lipid and protein moieties of oxLDL oxidized by ·OH/O2·- free radicals. We have shown that AMG inhibits lipid peroxidation and apo B fragmentation in a concentration-dependent manner, whereas AMG was only poorly efficient against apo B carbonylation. The scavenger receptor CD36 has been identified as one major receptor that internalizes oxLDL into macrophages. The second study aimed at comparing the effects of oxLDL and their oxidized products on the regulation of CD36 gene expression in human macrophages. We have shown that oxLDL and cholesteryl ester hydroperoxides increase CD36 gene expression in a pathway probably involving PPAR alpha
Kaščáková, Slávka. "The study of the interaction between hypericin and low-density lipoproteins (LDL) : the effect of the LDL receptors on the accumulation of the complex hypericin/LDL in glioma cells U-87 MG." Université d’Orléans, 2007. http://www.theses.fr/2007ORLE2081.
Full textThe incorporation and subcellular localization of photosensitizers (pts) are critical determinants of their efficiency in photodynamic therapy. The most important transporters of hydrophobie pts are low-density lipoproteins (LOL). Hypericin (Hyp) is a natural photosensitizing pigment. According to character of Hyp and possibility of its specific targeting into cells through LDL, the study of •. Interaction of Hyp with LDL is important. By means of absorption and fluorescence spectroscopy we showed, that Hyp binds to LOL as monomers up to concentration ratio Hyp/LDL = 30:1. Further increasing ofHyp concentration leads to the formation of Hyp aggregates inside LDL and/or dynamic self-quenching of Hyp. We demonstrated that photoactivated Hyp oxidizes LDL. The maximum of the oxidation of LDL by Hyp is achieved for ratio Hyp/LDL = 30: 1. For higher ratio a decrease in the oxidation of LDL was observed. Further the dependence of the uptake of Hyp by U-87 MG cells on the level of expression of LDL receptors was studied. The results show that the composition of incubation medium influences the concentration of Hyp in cells. The intracellular concentration of Hyp in the presence of LDL is proportional to the Hyp/LDL ratio. A role of LDL receptor pathway for Hyp delivery to cells was confinned by the increase of Hyp uptake in the presence ofLDL for the higher number of LDL receptors. The co-localization experiments showed the lysosomal localization of Hyp with enhanced Hyp concentration for cells with elevated number of LDL receptors when LDL was used as transporters. Our results suggest that LDL and its pathway play an important role in the Hyp delivery and accumulation into the cells
Alcouffe, Julie. "Effets inhibiteur et apoptotique des LDL oxydées sur les lymphocytes T activités : implication du système Fas-Fas ligand." Toulouse 3, 2003. http://www.theses.fr/2003TOU30016.
Full textAtherosclerosis and associated vascular accidents have become a major public health problem in industrialized countries. Oxidized low density lipoproteins (LDL) observed in atheroma are considered as essential actors in atherosclerosis pathogenesis. Oxidized LDL come from plasma LDL oxidization by vascular wall cells through mechanisms which remain rather unknown and confer oxidized LDL distinct biological properties. With the purpose to study the controversial role played by the immune system in atherosclerosis development, we attempted to characterize in vitro interactions between oxidized LDL and activated T lymphocytes in various T cell activation models. .
Castet, Valérie. "Infection in vitro des hépatocytes humains en culture primaire par le virus de l'hépatite C, rôle des candidats récepteurs CD81 et LDL-R." Montpellier 1, 2002. http://www.theses.fr/2002MON13516.
Full textRamin-Mangata, Stéphane. "Le rôle du récepteur aux LDL et de PCSK9 dans le diabète de type 2." Thesis, La Réunion, 2020. http://www.theses.fr/2020LARE0005.
Full textStatins are lipid-lowering drugs widely prescribed to prevent cardiovascular diseases. They inhibit the endogenous synthesis of cholesterol and thereby increase LDLR gene expression by activating the SREPB-2 transcription factor. The positive effects of statins regarding cardiovascular diseases are undisputable. However, their action is limited by the proprotein convertases subtilisin kexin type 9 (PCSK9), the natural inhibitor of the LDL receptor (LDLR), which is also activated by the SREBP-2 transcription factor. As a result, novel lipid-lowering strategies targeting circulating PCSK9 have emerged and have been approved recently. These are the PCSK9 inhibitors. Despite their well-established beneficial effects, the use of high doses of statins for long-term treatments induces in rare instances the onset of type 2 diabetes in predisposed individuals. In addition, “loss of function” genetic variants of PCSK9 are associated with an increased risk of type 2 diabetes. The effects of long term use of PCSK9 inhibitors on the risk of type 2 diabetes remain to be established. Thus, we hypothesized that cholesterol overload of insulin secreting pancreatic beta cells induced by the overexpression of the LDLR at their plasma membranes following treatment with statins and PCSK9 inhibitors may cause cell dysfunction, lower insulin secretion, and ultimately type 2 diabetes. The aims of my thesis were (i) to determine the circulating levels of PCSK9 and their modulation by statins in patients with type 2 diabetes, (ii) to determine if reduced circulating PCSK9 levels are predictive of new onset type 2 diabetes and finally (iii) to investigate the effect of statins, PCSK9, and PCSK9 inhibitors on beta cell function. Using three cohorts of patients, we showed that circulating PCSK9 plasma levels are increased in patients with type 2 diabetes and that reduced circulating PCSK9 levels are negatively associated with insulin resistance and elevated fasting blood glucose. In human pancreatic sections and human pancreatic beta cell lines, we showed for the first time that PCSK9 is expressed, synthesized and secreted only by beta cells in pancreatic islets. We did not find any significant effect of PCSK9 or PCSK9 inhibitors on glucose stimulated insulin secretion. Altogether, my thesis works underpin that the use of PCSK9 inhibitors in the clinic will probably not be diabetogenic. This is reassuring regarding the development of these new lipid-lowering therapies
Albecka, Anna. "Étude de l’entrée cellulaire du virus de l’hépatite C : rôle du récepteur aux LDL et identification de régions fonctionnelles des protéines de l’enveloppe virale." Thesis, Lille 1, 2010. http://www.theses.fr/2010LIL10143/document.
Full textTo initiate its life cycle, hepatitis C virus (HCV) needs to cross the cellular membrane. This process involves the viral envelope proteins and cellular receptor(s). During this thesis, we studied these two aspects. Our objectives were to identify new functional determinants in HCV glycoprotein E2 and to investigate the role of the LDL receptor (LDLR) during the HCV life cycle. With the hypothesis that E1 and E2 glycoproteins have co-evolved within the different genotypes, we identified functional intergenotypic incompatibilities between these two proteins. Based on a structural model, we then constructed several series of intergenotypic E2 chimeras. The functionality of these chimeras was analyzed in an infectious system and with the help of retroviral pseudotypes. This work led us to identify several E2 determinants involved in viral particle assembly as well as a juxtamembrane region taking part in virus entry. This latter has also been characterized at a structural level to better understand its role. Due to the potential interaction between HCV particle and low-density lipoproteins, the LDLR has been proposed as an entry factor for this virus. However, its exact role in HCV entry remains poorly understood. In this thesis, we investigated the role of this receptor in the HCV life cycle by comparing virus entry to the mechanism of lipoprotein uptake. We showed that the viral particle interacts with the LDLR. However, this interaction does not seem to lead to a productive infection. Furthermore, our data are in favour for a role of the LDLR as a lipid providing receptor which modules viral RNA replication
Yang, Xue. "Cucurbit[n]urils fonctionnalisés : transporteurs de médicaments avancés." Electronic Thesis or Diss., Aix-Marseille, 2020. http://www.theses.fr/2020AIXM0542.
Full textOne of the major problems of most medicines remains their poor targeting faculties toward pathological organs causing lots of side effects and/or restraining their therapeutic window. In an interdisciplinary approach at the nanoscale, we have built an advanced delivery system combining a macrocyclic molecular cargo (a cucurbit[7]uril or CB[7] having a pumpkin shape) and a vector peptide, selectively targeting Low Density Lipoprotein Receptors (LDLR) that are expressed at the surface of certain types of cancer cells or at the Blood Brain Barrier (BBB). The CB[7]-vector conjugate has shown excellent faculties of targeting and penetration in cells expressing LDLR. This work has thus allowed to combine two technologies by developing a multifunctional compound, versatile in its potential to transport a large palette of medicines toward pathological tissues expressing the target receptor
Boucher, Philippe. "Régulation nutritionnelle de l'expression des principaux gènes qui contrôlent le métabolisme et la toxicité de l'alcool et du cholestérol alimentaire : CYP2E1, LDL récepteurs, HMG CoA réductase et LRP." Lyon 1, 1999. http://www.theses.fr/1999LYO1T160.
Full textBooks on the topic "Récepteur des lipoprotéines de basse densité"
Cholesterol metabolism, LDL, and the LDL receptor. San Diego: Academic Press, 1990.
Find full text